Scarica l'app Stockscreener
472.64
1.68%
-8.10
Dopo l'orario di chiusura:
473.00
0.36
+0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$480.74
Aprire:
$482.96
Volume 24 ore:
1.95M
Relative Volume:
0.83
Capitalizzazione di mercato:
$178.47B
Reddito:
$43.21B
Utile/perdita netta:
$6.58B
Rapporto P/E:
27.34
EPS:
17.29
Flusso di cassa netto:
$6.17B
1 W Prestazione:
-0.82%
1M Prestazione:
-3.35%
6M Prestazione:
-9.03%
1 anno Prestazione:
-22.58%
Intervallo 1D:
$469.14
$486.57
Intervallo di 1 settimana:
$469.14
$492.00
Portata 52W:
$385.46
$623.76
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
472.64 | 181.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
192.94 | 136.39B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.66B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
126.72 | 36.06B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
186.69 | 31.76B | 15.70B | 1.24B | 2.01B | 6.91 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge - Yahoo Finance
Thermo Fisher Scientific Inc. $TMO Shares Acquired by New England Research & Management Inc. - MarketBeat
MassMutual Private Wealth & Trust FSB Purchases 1,384 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Czech National Bank Has $37.41 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Gradient Investments LLC Takes Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Equities Analysts Offer Predictions for TMO Q2 Earnings - MarketBeat
Rep. Kelly Morrison Sells Off Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock - sharewise.com
Thermo Fisher debuts multiplex protein panel for neurodegenerative disease research - Fierce Biotech
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink(R) Target 48 Neurodegeneration Panel - MarketScreener
Harvard Bioscience, Inc. Expands Distribution Agreement with Fisher Scientific to Include United States - MarketScreener
Thermo Fisher (TMO) Enhances U.S. Distribution for Harvard Biosc - GuruFocus
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States - The Manila Times
Avity Investment Management Inc. Trims Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Major Lab Equipment Distribution Deal: Harvard Bioscience Teams with Fisher Scientific Across US Market - Stock Titan
Trust Co. of Oklahoma Sells 1,203 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Wealth Alliance Advisory Group LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Boosted by Granite Bay Wealth Management LLC - MarketBeat
Value Partners Investments Inc. Buys 3,247 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Published on: 2025-09-16 13:53:34 - خودرو بانک
Thermo Fisher Scientific Inc. $TMO Position Lifted by Wesbanco Bank Inc. - MarketBeat
Canandaigua National Bank & Trust Co. Sells 545 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
RMR Wealth Builders Has $1.45 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Lingohr Asset Management GmbH Reduces Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Legacy Private Trust Co. - MarketBeat
Quintet Private Bank Europe S.A. Reduces Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
S.E.E.D. Planning Group LLC Raises Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Douglas Lane & Associates LLC Has $80.90 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lifted by E. Ohman J or Asset Management AB - MarketBeat
Salem Investment Counselors Inc. Sells 1,748 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Parallel Advisors LLC Trims Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Clinical Genomics Market Opportunity Analysis and Industry - openPR.com
Thermo Fisher Scientific unveils Efficient-Pro Medium (+) Insulin - Medical Dialogues
Epigenetics Market Outlook (2025–2032) : Strategic Growth Insights, Revenue Trends and Innovation Amidst Leaders Like Illumina Inc., Thermo Fisher Scientific Inc. - industrytoday.co.uk
Strs Ohio Buys New Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Rating Increased to Overweight at Barclays - MarketBeat
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel - BioSpace
Foresight Group Ltd Liability Partnership Has $29.11 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Intech Investment Management LLC Purchases 5,769 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Macro Review: Will Thermo Fisher Scientific Inc outperform the market in YEARQuarterly Earnings Report & Verified Swing Trading Watchlists - خودرو بانک
Stock Market Recap: Does Thermo Fisher Scientific Inc. meet Warren Buffett’s criteriaJuly 2025 Breakouts & Daily Profit Focused Stock Screening - خودرو بانک
Thermo Fisher: A Hold For Stability, Not For Outperformance (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin - Contract Pharma
Thermo Fisher unveils Gibco Efficient-Pro Medium (+) Insulin for better bioprocessing - BioSpectrum Asia
US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - GlobeNewswire
Analysis Recap: Does Thermo Fisher Scientific Inc. outperform in volatile markets2025 Pullback Review & Weekly Sector Rotation Insights - خودرو بانک
Growth Value: Will Thermo Fisher Scientific Inc. outperform the market in YEARJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - خودرو بانک
Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance - MarketScreener
Thermo Fisher Scientific (NYSE:TMO) CEO Marc N. Casper Sells 400 Shares - MarketBeat
Thermo Fisher Scientific Inc. $TMO Position Lifted by Doliver Advisors LP - MarketBeat
Jacobs & Co. CA Raises Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):